Economists continue to show optimism…
- When we combine even more spending with vaccines and warmer weather, the US economy should keep growing. We expect real GDP to grow 4.0% in 2021 (Q4/Q4) while payrolls expand by six million. Read more… – Brian Wesbury, Chief Economist, First Trust
- The spreading pandemic is slowly and painfully adding to the number of Americans with at least partial immunity to the virus. In addition, the approval of two apparently very effective vaccines in the U.S. in December should allow for the inoculation of roughly 150 million people in the first half of 2021. Assuming that further vaccines are also approved, growing immunity, along with better testing and therapeutic drugs, should allow the number of cases and fatalities to drop precipitously over the summer, allowing life to largely return to normal by the fall of 2021. – Dr. David Kelly, Chief Strategist, JPMorgan Funds
- We are confident that we will see another round of fiscal stimulus – despite recent partisan rumblings in Congress, and we think we are nearing the end of the health care crisis. This should continue to reinforce our modest risk-on positioning based on earnings growth driven by the expected economic recovery later this year. Read more… – Saira Malik, CIO, Head of Global Equities, Nuveen
As always, we continue to believe that one’s circumstances and risk profile should determine the appropriate mix of investments, and not media headlines. Please contact us if you ever have any questions or concerns about your accounts or any news you hear.
Past performance may not be indicative of future results. Therefore, no current or prospective client should assume that the future performance of any specific investment, asset class, or investment strategy (including the investments and/or investment strategies recommended by the adviser), will be profitable or equal to past performance levels. Information in this commentary is gleaned from third party sources, and while believed to be reliable, is not independently verified.